Johnson & Johnson (JNJ) Research & Development (2009 - 2026)
Johnson & Johnson (JNJ) posted Research & Development of $3.65 billion for Q2 2026, up 3.9% from $3.52 billion a year earlier and up 3.6% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Research & Development (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 28, 2026, Research & Development at Johnson & Johnson was $15.1 billion, down 11.1% year-over-year; for FY2025, it came in at $14.67 billion, down 14.9% from FY2024.
- Annual Research & Development shows a four-year compound annual growth rate of 4.8% (FY2021 to FY2025).
- In prior years, Johnson & Johnson's Research & Development was $17.23 billion in FY2024 (+14.2%), $15.09 billion in FY2023 (+6.7%), $14.14 billion in FY2022 and $12.16 billion in FY2021.
- Quarterly Research & Development has run from a low of $3.23 billion in Q1 2025 to a high of $5.3 billion in Q4 2024 over five years.
- On a year-over-year basis, Research & Development increased in five of the last eight quarters, with growth averaging 2.9%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2024, with growth of 43.7%; the weakest was Q3 2025, with a decline of 25.8%.
- According to Business Quant data, Research & Development for the three prior quarters was $3.53 billion (Q1 2026), $4.25 billion (Q4 2025) and $3.67 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 2.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 3.65 Bn |
| Mar 29, 2026 | 3.53 Bn |
| Dec 28, 2025 | 4.25 Bn |
| Sep 28, 2025 | 3.67 Bn |
| Jun 29, 2025 | 3.52 Bn |
| Mar 30, 2025 | 3.23 Bn |
| Dec 29, 2024 | 5.30 Bn |
| Sep 29, 2024 | 4.95 Bn |
| Jun 30, 2024 | 3.44 Bn |
| Mar 31, 2024 | 3.54 Bn |
| Dec 31, 2023 | 4.48 Bn |
| Oct 1, 2023 | 3.45 Bn |
| Jul 2, 2023 | 3.70 Bn |
| Apr 2, 2023 | 3.46 Bn |
| Jan 1, 2023 | 4.14 Bn |
| Oct 2, 2022 | 3.49 Bn |
| Jul 3, 2022 | 3.70 Bn |
| Apr 3, 2022 | 3.46 Bn |
| Jan 2, 2022 | 6.15 Bn |
| Oct 3, 2021 | 3.42 Bn |
API Access
Johnson & Johnson Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();